Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Investigation
03/03/2021
Initial Lawsuit
03/03/2021
Lawsuit Progression
07/14/2021
Investigation regarding Ontrak’s relationship with its largest customer Aetna (on a provider basis) and the June 2021 contract termination.
03/01/2021
Ontrak releases its Q4 2020 financial results. The company announces that its largest customer, Aetna, will terminate its relationship with Ontrak on June 26, 2021. “We were advised to stop enrollment of new members for this customer and await guidance from the customer on transition plans for the 8,400 members who are currently benefiting from the Ontrak program.”
Ontrak also discloses that its relationship with Aetna was unique because they evaluated Ontrak as a provider: “the relationship with our Ontrak-A customer was unique, because they evaluated Ontrak on a provider basis, not as a vendor as do all of our other health plan partners. As such, the customer evaluated our performance based on our ability to achieve the lowest possible cost per medical visit, and not on our clinical outcomes data or medical cost savings, which were meaningful and significant.“
See more on Factual TimelinePlaintiff brings this class action on behalf of persons and entities that purchased or otherwise acquired Ontrak securities between November 5, 2020 and February 26, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings;
(2) that, as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak;
(3) that, because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and
(4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
07/14/2021
The court issued an order appointing the lead plaintiff and lead counsel.
08/23/2021
Lead plaintiff brings this securities class action on behalf of a class consisting of all persons and entities that purchased Ontrak publicly traded common stock on U.S. Exchanges between August 5, 2020 and February 26, 2021, inclusive.
Operative complaint
09/13/2021
A motion to dismiss was filed with the court.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.